<qa>  What is the purpose of the TRIAL to ASSESS SAFETY, TOLERABILITYA TRIAL TO ASSESS THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF REPEVAX AND RLP2086 VACCINE WHEN GIVEN TOGETHER IN HEALTHY SUBJECTS AGED 11 TO 19 YEARS.: 